Newsroom

AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences

LEXINGTON, Mass., Sep 12, 2011 (BUSINESS WIRE) — AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that members of management will be participating in the following investor conferences:




  • Morgan Stanley Global Healthcare Conference, September 14 at 2:10 p.m. ET in New York City

  • UBS Global Life Sciences Conference, September 19 at 8:00 a.m. ET in New York City

A live webcast of each presentation will be accessible through the Investors section of the company’s website at https://www.amagpharma.com. Following each conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website for approximately two weeks.


About AMAG Pharmaceuticals, Inc.


AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit https://www.amagpharma.com.


SOURCE: AMAG Pharmaceuticals, Inc.


AMAG Pharmaceuticals, Inc.
Carol Miceli, 617-498-3361